University of Rochester HIV/AIDS Clinical Trials Unit

$290,519UM1FY2020AINIH

University Of Rochester, Rochester NY

Investigators

Linked publications, trials & patents

Paper 38947062 Paper 38306894 Paper 38160309 Paper 38051788 Paper 37910437 Paper 37795976 Paper 37183889 Paper 36540980 Paper 36179551 Paper 36131068 Paper 34398236 Paper 34185068 Paper 34117753 Paper 33901188 Paper 33887209 Paper 33252493 Paper 33066718 Paper 33016926 Paper 32829410 Paper 32577626 Paper 32496516 Paper 32437332 Paper 32123636 Paper 31822125 Paper 31656054 Paper 31566579 Paper 31434737 Paper 31131858 Paper 30939531 Paper 30926296 Paper 30864331 Paper 30668695 Paper 30642925 Paper 30427829 Paper 30364428 Paper 30235286 Paper 30134291 Paper 29847509 Paper 29709783 Paper 29659751 Paper 29590326 Paper 29461980 Paper 29401318 Paper 29218904 Paper 29171837 Paper 29135907 Paper 28931520 Paper 28875397 Paper 28727817 Paper 28391912 Paper 28365413 Paper 28263464 Paper 28263459 Paper 28099408 Paper 27612555 Paper 27413359 Paper 27379802 Paper 27281061 Paper 27277877 Paper 26979419 Paper 26877758 Paper 26776173 Paper 26761518 Paper 26733388 Paper 26587311 Paper 26544577 Paper 26475930 Paper 26413850 Paper 26333941 Paper 26332672 Paper 26229114 Paper 26180834 Paper 26148204 Paper 26060295 Paper 26009829 Paper 25948863 Paper 25897603 Paper 25884002 Paper 25851992 Paper 25820067 Paper 25642120 Paper 25624326 Paper 25461247 Paper 25377444 Paper 25285539 Paper 25253665 Paper 25214516 Paper 25159623 Paper 25079889 Paper 25024383 Paper 24990385 Paper 24815851 Paper 24759064 Paper 24729586 Paper 24723284 Paper 24557078 Paper 24554482 Paper 24525470 Paper 24518211 Paper 24403557

Abstract

The University of Rochester (UR) Clinical Microbiology laboratory is a CLIA-certified laboratory that offers bacteriology (ID and susceptibility), immunology, mycobacteriology, mycology, parasitology, serology, TB and virology testing including specialized antibiotic and antifungal studies. The laboratory evaluates and adds infectious diseases molecular diagnostic tests on an ongoing basis and has sufficient capability for SARS-CoV-2 RNA testing to meet current clinical demands.

View original record on NIH RePORTER →